Methylphenidate Stada

Methylphenidate, the active ingredient in Methylphenidate Stada, is a central nervous system stimulant presented as an oral formulation for oral use. It treats attention deficit hyperactivity disorder (ADHD) and narcolepsy in children, adolescents, and adults.

GNH USA supplies Methylphenidate Stada as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Methylphenidate Stada is a psychostimulant indicated for disorders affecting attention and wakefulness. - Attention deficit hyperactivity disorder (ADHD): improves focus, reduces hyperactivity and impulsivity. - Narcolepsy: decreases excessive daytime sleepiness and improves alertness. - ADHD in adults: supports symptom control and functional performance.

Methylphenidate may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Insomnia - Decreased appetite - Headache - Stomach pain

Serious or Rare Side Effects: - Cardiovascular events such as hypertension or tachycardia - Psychotic symptoms including hallucinations or delusions - Severe allergic reactions, for example rash, swelling or anaphylaxis

Before prescribing Methylphenidate Stada, clinicians should consider several safety measures. - Assess cardiovascular status: evaluate blood pressure and heart rate prior to initiation. - Monitor growth in children: regularly track height and weight. - Avoid use in patients with known hypersensitivity: discontinue if allergic reaction occurs. - Use caution with pre‑existing psychiatric conditions: observe for mood changes or emergence of psychosis. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Methylphenidate Stada can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis. - Antihypertensive agents: may reduce blood‑pressure control effectiveness. - Tricyclic antidepressants: increased risk of cardiovascular side effects.

Moderate Interactions (Monitor Closely): - Proton pump inhibitors: may alter drug absorption. - Alcohol: can enhance central nervous system stimulation and cardiovascular effects.